IN­DRAPRASTHA MED­I­CAL CORP.

Dalal Street Investment Journal - - QUERY BOARD -

In­draprastha Med­i­cal Cor­po­ra­tion Limited is an In­di­a­based­spe­cialty care­com­pany en­gaged in health­care busi­ness. The com­pany pro­vides di­ag­nos­tic, med­i­cal, and sur­gi­cal fa­cil­i­tiesto its pa­tients. It­pro­vides var­i­ous surgery ser­vices, in­clud­ing gas­troen­terol­ogy and GI, car­dio­tho­racic, and oth­ers.

On the fi­nan­cial front, In­draprastha Med­i­cal Cor­po­ra­tion posted 4.80 per cent de­cline in its net sales to ₹184.24 crore in the first quar­ter of FY18, as against ₹193.53 crore in the same quar­ter of the pre­vi­ous fis­cal. The com­pany’s PBIDT de­clined by 20.95 per cent to ₹16.91 crore in Q1FY18 as com­pared to ₹21.39 crore in the same quar­ter of the pre­vi­ous fis­cal. The profit af­ter tax of the com­pany de­creased by 41.84 per cent to ₹4.76 crore in the first quar­ter of FY18 as against ₹8.19 crore in the same quar­ter of the pre­vi­ous fis­cal. On an an­nual ba­sis, the com­pany’s net sales dropped by 0.47 per cent to ₹729 crore in FY2017 on a year-onyear ba­sis. The com­pany’s PBIDT de­clined by 2.17 per cent to ₹77.66 crore in FY17 as against ₹79.38 crore in the pre­vi­ous fis­cal. How­ever, the com­pany’s profit af­ter tax in­creased by 7.45 per cent to ₹26.25 crore in FY2017 as against ₹24.45 crore in the pre­vi­ous fis­ca­lyear. The stock has a strong growth mo­men­tum. We rec­om­mend the reader-in­vestors to Hold the stock.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.